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SUMMARY To summarise the skeletal, dental and
soft tissue effects of orthopaedic treatment on
growing skeletal class III patients compared with a
concurrent untreated similar control group and to
evaluate whether the design of the primary studies
may affect the results. A literature search was
performed up to the end of February 2016. No
restrictions were applied concerning language and
appliances. Once the quality score was assessed, a
meta-analysis was performed for the appliances
used in more than three studies. A moderator
analysis for study design was performed. The level
of evidence was evaluated by means of the Grades
of Recommendation, Assessment, Development
and Evaluation (GRADE) tool. The search resulted
in 21 papers. The quality of most of the studies
was medium. Each study reported skeletal sagittal
improvement and overjet correction. Fourteen
studies reported a significant increase in lower
facial height. Follow-up data showed slight
relapses in about 15% of patients. Meta-analyses
were performed for the facemask and chin cup.
The two appliances were efficient for correcting
the sagittal discrepancy, increasing the divergence.
In the analysis for study design, the retrospective
studies showed a more efficient appliance than
RCTs for 6 of 13 variables. The level of evidence
was between very low and moderate. There is very
low to low evidence that orthopaedic treatment is
effective in the correction of Class III skeletal
discrepancies and moderate evidence for the
correction of the overjet. A common side effect is
mandibular clockwise rotation in older subjects.
KEYWORDS: malocclusion, angle class III, orthodon-
tic appliances, meta-analysis, evidence-based
dentistry, child, growth and development
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Background
Skeletal class III malocclusion is one of the most investi-
gated topics in orthodontics (1–9). The skeletal and dental
components of Class III malocclusions are usually estab-
lished since early childhood (1, 2) and may worsen with
growth (3–5). In the majority of cases, without any treat-
ment during childhood, orthognathic surgery is the only
option to establish a correct occlusion (6, 7). However,
early interception of this malocclusion may represent an
opportunity to avoid or reduce the risk of surgery (8, 9).
Several orthopaedic appliances are used in the early
treatment of this malocclusion, such as the Frankel III
(FR-III) (10), chin cup (CC) (11), mandibular head-
gear (MHG) (12), reverse headgear (RPHG) (13) or
facemask (FM) (14), and bone-anchored maxillary
protraction (BAMP) (15).
Actually, there is still a lack of evidence concern-
ing the effectiveness of orthopaedic Class III
treatments, particularly regarding the changes in
sagittal and vertical dimension and long-term
stability.
Six systematic reviews and meta-analysis have
recently been published on skeletal Class III malocclu-
sion treatment (16–22), only focusing on RCTs or a
single appliance.
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The aim of the present systematic review was to
summarise the skeletal, dento-alveolar and soft tissue
effects of orthopaedic treatment on growing patients
with skeletal Class III malocclusion by answering the
following question according to the PICO schema
(23): ‘Do growing skeletal Class III patients (P) treated
with an orthopaedic appliance (I) show improvement
in skeletal, dental or soft tissues outcomes in the short
and long term (O), as opposed to an untreated con-
current control group of growing skeletal Class III
patients (C)?’ The meta-analysis aimed to assess the
efficacy of the treatment and verify if the design of
the primary studies affects the reported results.
Methods
Search strategy and study collection
This systematic review is based on the PRISMA guide-
lines for systematic reviews and meta-analyses (24). A
literature survey was performed up to the end of
February 2016 using the following search engines:
PubMed, Literature in the Health Sciences in Latin
America and the Caribbean (LILACS), Scientific Elec-
tronic Library Online (SciELO), Cochrane Central
Register of Controlled Trials, Scopus, Web of Knowl-
edge, Cambridge Scientific Abstracts, UMI ProQuest
metaRegister of Controlled Trials. No restrictions were
applied concerning language and appliances. Article
abstracts were reviewed to select papers in which an
orthopaedic treatment device was used. To minimise
the risk of omitting any relevant literature, two
authors (IP, RR) independently performed the first
step of the screening procedure. The reference lists of
the selected articles were hand searched for possible
missing articles. Furthermore, the same authors car-
ried out the hand search of American Journal of
Orthodontics and Dentofacial Orthopedics, The Angle
Orthodontist, Orthodontic and Craniofacial Research
and European Journal of Orthodontics.
The research focused on orthopaedic therapy for
growing Class III patients and each database had a
specific research strategy (Table S1).
Selection criteria
The study included randomised clinical trials (RCT),
prospective non-randomised clinical trials (CCT) and
retrospective non-randomised clinical trials (Ret),
with or without follow-up. Other studies, such as sys-
tematic reviews, reviews, case reports, case series,
opinion articles or letters to the editor, were excluded
(Table S2).
Two reviewers (IP, RR) independently assessed the
studies. Disagreements on the selection were resolved
through discussion and if necessary consulting a third
reviewer (VD).
Quality scores of the included studies
Two reviewers (AM, RM) independently evaluated the
quality scores using a modified Downs and Black
checklist (25). In this checklist, there are five main
domains: reporting, external validity, internal validity-
bias, internal validity-confounding and power. The
maximum score is 27. A study was judged of low
quality if the score was lower than 16, medium quality
from 17 to 20, medium-high quality from 21 to 23,
and of high quality from 24 to 27. The concordance
level was assessed by means of Cohen’s k. Moreover,
the Cochrane risk of bias tool (26) was used to assess
the RCTs. Disagreements were solved by discussion or
after consulting the third reviewer (VD).
Data extraction
Two examiners (RB, VD) extracted the data indepen-
dently using a customised form. The following data
were extracted: author and year of publication, study
design, ethnic group, sample size, treatment, full
observational period, class III diagnosis, inclusion cri-
teria, treatment time, success description, success rate,
main treatment effects (skeletal, dental, soft tissue),
side effects, follow-up, cephalometric values (SNA,
SNB, ANB, maxillary length, mandibular length,
mandibular divergence, upper incisors inclination,
lower incisors inclination, overjet, overbite, upper lip
position, lower lip position and profile variation).
Statistical analysis
Two different meta-analyses were performed: one
including studies on FM/RPHG/MBPA (maxillary bow
protraction appliance) and the other including studies
on CC. All the data were annualised, and the ran-
dom-effects model was chosen as the observed effect
was expected to differ across studies due to sample
differences. Statistical heterogeneity was explored
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using a test for heterogeneity (I2), the level of signifi-
cance was set at P < 010 two-sided and a moderator
analysis was performed. Subgroup analysis or meta-
regression was performed, when possible, for study
design, mean patient age at the beginning of the
treatment, presence of an expansion phase, treatment
duration and gender. For continuous data, the
Cohen’s d coefficient or standard mean difference
(SMD) with a 95% confidence interval, as well as the
standard error, was calculated, using different meth-
ods according to the data available from the primary
studies or after a request of the authors. The statistical
significance of the hypothesis test was set at P < 005
(two-tailed Z-tests). Egger’s test was chosen to detect
publication bias if the number of included studies
exceeded 10 (P < 010).
Evaluation of the level of evidence
The level of evidence was calculated using the Grades
of Recommendation, Assessment, Development and
Evaluation Pro (GRADEpro GDT: GRADEpro Guide-
line Development Tool [Software], Available from
gradepro.org.) software. This approach considers five
aspects for overall risk of bias: directness of the evi-
dence, consistency of the results, precision of the esti-
mates, risk of publication bias and magnitude of the
effect (27). The quality of the body of evidence was
categorised as high, moderate, low or very low. Only
RCTs were included in this analysis.
Results
Search results
The search results and the flow chart of the studies
included for the analysis are shown in Table S1 and
Table 1. The literature search resulted in 3745 pub-
lished articles, of which 109 were considered poten-
tially relevant. An independent review of the 109
full-text articles led to the exclusion of 88. The most
common causes were absence of control [15], control
group not of Class III [19], historical control group
[23] and the absence of cephalometric analysis [17]
(Table S3). The final sample consisted of 21 articles
(12–14, 28–46) and comprised seven RCT, eight CCT
and six Ret studies (Table S4).
Of 21 studies, 13 were analysed in the meta-analy-
sis of FM with 15 independent treated groups
examined (13, 14, 30, 31, 33–35, 38, 40, 42–45), and
three studies (12, 28, 41) with four independent trea-
ted groups were analysed in the meta-analysis of CC.
Characteristics of the studies
The age range of the treated group was between
56  10 years (34) to 125  07 years (45) while the
control group ranged from 48  14 years (34) to
115  11 years (30). The treatment time variation
was from 52 months (34) to 60 months (32) although
it was not reported in one paper (28). The full observa-
tional time was often similar to the treatment time
because only two studies reported follow-up data (14,
30). Many appliances were used in these studies: the
CC was used in three studies (12, 28, 41), and 16 stud-
ies used only FM (13, 30, 33–35, 40, 42, 43, 45), or FM
associated with expansion (RME+FM) (14, 38, 40, 43,
44), with Bionator III (FM+BIO) (31), with miniplates
(FM+MP) (38, 39) or with splints (FM+splint) (44) in at
least one group. Only 13 of 21 studies based the skeletal
Class III diagnosis on cephalometric criteria. Success
description was reported in 16 studies, including
mainly dental outcomes (Table S4).
Quality assessment
The quality assessment is shown in Table 2. In partic-
ular, only two studies (14, 37) had a blinded design
and four studies (14, 37, 39, 44) examined the study
power (a priori or a posteriori). Furthermore, three
studies (14, 37, 44) analysed the methodological error
and 11 studies had an adequate statistical analysis.
Interestingly, only three studies (32, 39, 46) did not
have a sufficient external validity due to the distribu-
tions of the confounding factors. Two RCTs of seven
(14, 37) achieved the maximum score in both internal
validity domains. The two examiners presented a high
level of concordance (k = 088). The Cochrane risk of
bias tool results are shown in Table 3.
Skeletal effects
All the studies reported skeletal effects of the treat-
ment. On the sagittal plane, most of the studies
showed effects on both the maxilla and mandible,
depending on the appliance used. The best improve-
ment of the ANB, SNA and SNB angles was in the
Kajiyama (34) study (+783°, +416°, 366°). The
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biggest increase of maxillary length (+44 mm) was in
Falck and Zimmermann-Menzel’s (32) study using
FR-III, while with RME+FM the greatest increase was
reached in Vaughn’s study (43) (+429 mm). The
highest control of mandibular length was in the Yagci
and Uysal study (44) with RME+FM (64 mm). Two
studies reported significant effects only on the upper
jaw (31, 42) (Tables S5 and S6).
In the FM meta-analysis, strong effects were found
on ANB, SNA, SNB, with a significant Egger’s test:
ANB (P < 0001); SNA (P < 0001); SNB (P = 0016)
(Fig. 1a–c). Some moderators explained the hetero-
geneity of ANB and SNA, in fact for both variables,
the Ret studies presented better results (ANB,
P = 0001; SNA, P = 0004) (ANB, SMD = 663
CI = 382–944, SNA, SMD = 368 CI = 217–520)
than CCT (ANB, SMD = 309 CI = 218–4, SNA,
SMD = 174 CI = 095–254) and RCT (ANB, SMD =
190 CI = 130–25, SNA, SMD = 105 CI = 051–159)
(Figure S1a,b). Moreover, changes in SNA were lower
(P = 0038) with expansion than without expansion
(EXP, SMD = 141 CI = 068–213, NO EXP, SMD =
264 CI = 173–355) (Figure S1c).
For maxillary length a significant increase was
found with a significant Egger’s test (P < 0001)
(Fig. 2a). The high heterogeneity might be explained
by an effect of the study design (P = 0008) as Ret
studies showed higher values (SMD = 354 CI = 126–
581), than the CCT (SMD = 071 CI = 026–115) and
RCT (SMD = 151 CI = 099–203) (P = 0008)
Table 1. Flow diagram of the
included study
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(Figure S2a). The FM also produced an effect on
mandibular length (Fig. 2b), and this parameter was
unaffected by publication bias (P = 051). None of the
analysed moderators was able to explain the medium
heterogeneity.
In CC meta-analysis, significant changes were
found for ANB, SNA and SNB (Fig. 1a–c), while there
was no effect on mandibular length (Fig. 2b). No data
were found on maxillary length.
The GRADE scale showed a low level of evidence
that FM produced a decrease of SNB and a very low
level of evidence that it corrected ANB and SNA, due
to the high chance of a publication bias. Moreover,
there was a very low level of evidence that the FM
Table 3. Cochrane risk of bias tool (26)
Abdelnaby and
Nassar (28)
Arun and
Erverdi (12)
Atalay and
Tortop (29)
Kilicoglu and
Kirlic (35)
Mandall
et al. (14)
Saleh
et al. (37)
Vaughn
et al. (43)
Sequence generation Unclear Low risk Low risk Unclear Low risk Low risk Low risk
Allocation concealment Unclear High risk High risk Unclear Low risk Low risk Unclear
Blinding of participants,
personnel and outcome
assessors
Unclear High risk High risk Unclear Low risk Low risk Low risk
Incomplete outcome data Unclear Low risk Low risk Unclear Low risk Low risk Unclear
Selective outcome reporting Low risk Low risk Low risk Low risk Low risk Low risk Low risk
Other sources of bias High risk Low risk Low risk Low risk Low risk Low risk Low risk
Overall risk of bias High risk High risk High risk Unclear Low risk Low risk Unclear
Table 2. Risk of bias analysis of the included studies according to the Downs and Black scale (25)
Reporting
(11)
External
validity (3)
Internal
validity
(Bias) (6)
Internal
validity (Selection
bias) (6) Power (1) Total
Abdelnaby and Nassar (28) 8 3 4 4 0 19 Medium quality
Arun and Erverdi (12) 7 3 5 4 0 19 Medium quality
Atalay and Tortop (29) 8 3 5 4 0 20 Medium quality
Chen et al. (30) 9 3 4 3 0 19 Medium quality
Cozza et al. (31) 8 3 4 3 0 18 Medium quality
Falck and Zimmermann-
Menzel (32)
6 2 4 3 0 15 Low quality
G€oyenc and Ersoy (13) 10 3 5 3 0 21 Medium-high quality
Kajiyama et al. (33) 8 3 3 2 0 16 Low quality
Kajiyama et al. (34) 8 3 2 3 0 16 Low quality
Kilicoglu and Kirlic (35) 8 3 4 3 0 18 Medium quality
Mandall et al. (14) 10 3 6 6 1 26 High quality
Saleh et al. (37) 9 3 6 6 1 25 High quality
Sar et al. (38) 9 3 4 3 0 19 Medium quality
Sar et al. (39) 6 2 5 3 1 17 Medium quality
Tortop et al. (40) 9 3 5 3 0 20 Medium quality
Tuncer et al. (41) 9 3 3 2 0 17 Medium quality
Ucem et al. (42) 8 3 5 3 0 19 Medium quality
Vaughn et al. (43) 8 3 4 4 0 19 Medium quality
Yagci and Uysal (44) 10 3 5 4 1 23 Medium-high quality
Yuksel et al. (45) 9 3 4 3 0 19 Medium quality
Zhao et al. (46) 10 2 4 2 0 18 Medium quality
In the brackets the maximum score achievable for each domain.
≤16: low quality; 16 < x ≤ 20: medium quality; 20 < x ≤ 24: medium-high quality; 24 < x ≤ 27: high quality.
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Fig. 1. Meta-analyses of ANB (a), SNA (b) and SNB (c) changes when comparing the orthopaedic treatment with the chin cup (CC)
and with the facemask (FM) with no treatment. Forest plot for the standard mean including the source studies, effect sizes with 95%
confidence intervals, statistical significance, number of total (N), treated (N1) untreated (N2) participants and assessments of hetero-
geneity (I2).
© 2017 John Wiley & Sons Ltd
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Fig. 2. Meta-analyses of maxillary length (a), mandibular length (b) and mandibular divergence (c) changes when comparing the
orthopaedic treatment with chin cup (CC) and with the facemask (FM) with no treatment. Forest plot for the standard mean includ-
ing the source studies, effect sizes with 95% confidence intervals, statistical significance, number of total (N), treated (N1) untreated
(N2) participants and assessments of heterogeneity (I2).
© 2017 John Wiley & Sons Ltd
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controlled mandibular growth and promoted maxil-
lary growth due to the high risk of bias and the small
sample size of the considered studies (Table 4). For
CC the level of evidence was very low for the follow-
ing outcomes: ANB, SNA, SNB and mandibular length
for the high risk of bias (Table 5).
Regarding vertical changes 6 of 21 studies showed a
counterclockwise rotation of the mandible (32, 37) or
stability of patient divergence (13, 31, 42, 45). The
greatest counterclockwise rotation was in Falck’s
study (32) with a reduction of the gonial angle of
717° and of 515° for the mandibular plane angle.
On the other hand, 15 studies reported a significant
increase in mandibular divergence. Yagci and Uysal
(44) reported the highest increase in SN-Mp +42°
(Tables S5 and S6).
In the meta-analysis of FM there was an increase in
mandibular divergence with a significant (Fig. 2c)
Egger’s linear regression (P = 0031). The mandibular
divergence was influenced by the age of treatment:
the older the patient, the higher the degree of clock-
wise rotation (Slope = 024; P = 0027) (Figure S2c).
In addition, CC caused a clockwise rotation of the
mandible (Fig. 2c).
Finally, according to the GRADE evaluation, there
was a low level of evidence that FM increased the
mandibular divergence and a very low level of evi-
dence for CC (Tables 4 and 5).
Dental effects
One study did not evaluate dental effects of the
orthopaedic treatment (41). The overjet was always
corrected during facemask treatment, but only eight
studies reported data (14, 29, 38–40, 42, 45, 46)
(Table 5; Table S5). In FM meta-analysis, there was a
significant correction of the overjet (Fig. 3a). Two of
the moderators assessed explained in part the high
heterogeneity; in fact, retrospective studies (P < 0001)
(Ret, SMD = 1179 CI = 907–1451, P < 0001; CCT,
SMD = 627 CI = 453–801, P < 0001; RCT,
SMD = 187 CI = 132–242, P < 0001) and no expan-
sion (P = 0011) (NO EXP, SMD = 1267 CI = 940–
1594, P < 0001; EXP, SMD = 567 CI = 135–999,
P < 001) reported greater values of overjet correction
(Figure S3a,b). Overbite was evaluated in seven studies
(29, 38–40, 42, 45, 46), and in six of seven studies the
overbite significantly decreased. Four studies included
in FM meta-analysis showed a significant decrease
(Fig. 3b). The subgroup analysis revealed that retrospec-
tive studies (P < 0001) (Ret, SMD = 395 CI = 493
to 298, P < 0001; CCT, SMD = 095 CI = 171 to
020, P = 0013) and no expansion (P = 0026) (NO
EXP, SMD = 432 CI = 528 to 336, P < 0001;
EXP, SMD = 187 CI = 38 to 006, P = 0026) had a
greater decrease in overbite (Figure S3c,d).
Two studies did not evaluate incisor inclinations
(37, 45) and another evaluated only upper incisor
inclination (43). Four papers did not find any change
in incisors inclination after treatment with CC, MHG
or FM (12, 31, 40, 44). At the end of the functional
treatment, six studies found a retroclination or a
stable position of upper incisors (14, 35, 38, 39, 43,
44) while eleven showed a proclination (13, 29, 30,
32–34, 38, 39, 42, 45, 46); three found a proclination
or a stable position of lower incisors (13, 30, 39)
while nine showed a retroclination (13, 28, 29, 33,
34, 38, 39, 42, 46) (Tables S5 and S7).
The meta-analysis for FM found a significant procli-
nation on the upper incisors (Fig. 3c) without a publi-
cation bias (P = 0943). The study design (P = 0028)
affected the result with RCTs (SMD = 010 CI = 032
to 052), showing no effects together with Ret
(SMD = 072 CI = 048 to 193) while CCT showed
a higher effect (SMD = 082 CI = 050–115) (Fig-
ure S4a). Only 10 of 13 studies included in the meta-
analysis of FM evaluated the inclination of the lower
incisors and did not find a significant effect of the
appliance (Fig. 3d), and this parameter was not
affected by a publication bias (P = 082). None of the
analysed moderators explained the heterogeneity.
For CC no data were available on overjet and over-
bite, and only one study (28) was included in the
meta-analysis, which showed a significant proclina-
tion of upper incisors and retroclination of lower inci-
sors (Fig. 3c,d).
According to the GRADE, there was a moderate
level of evidence that FM corrected the overjet, a low
level of evidence that FM did not have any effects on
the upper incisors and a very low level that it pro-
duced a retroclination of the lower incisors (Table 4).
Also for CC, the level of evidence was very low for
the dental inclinations (Table 5).
Soft tissue effects
Only 10 studies, one with a removable mandibular
retractor (RMR) (37), one with a magnetic orthopaedic
© 2017 John Wiley & Sons Ltd
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Fig. 3. Meta-analyses of overjet (a), overbite (b), upper incisor inclination (c) and lower incisor inclination (d) changes when com-
paring the orthopaedic treatment with chin cup (CC) and with the facemask (FM) with no treatment. Forest plot for the standard
mean including the source studies, effect sizes with 95% confidence intervals, statistical significance, number of total (N), treated (N1)
untreated (N2) participants and assessments of heterogeneity (I2).
© 2017 John Wiley & Sons Ltd
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appliance (MOA-III) (46) and eight with an FM (13,
31, 35, 38, 39, 42–44), reported effects on the profile.
All studies described positive profile changes and just
one showed a stable position of the lower lip (46)
(Tables S5 and S8). The meta-analysis on FM showed
a significant advancement of the upper lip, control of
the lower lip and improvement of the profile
(Fig. 4a–c). Furthermore, in the moderator analysis,
the upper lip position was influenced by age at treat-
ment start; in fact, the FM might cause a higher
improvement in younger patients (Slope = 073;
P = 0003) (Figure S4b).
The level of evidence assessed by the GRADE was
very low for the three parameters (Table 4).
The meta-analysis for CC did not present any study
that assessed soft tissue changes.
Follow-up data
Only two studies have follow-up information and
both used FM. Chen et al. (30) reported a 2-year fol-
low-up of ten patients. Among these, six had stable
mandibular growth and decreased ANB, while four
had maxillary retrusion, mandible protrusion and hor-
izontal mandibular growth direction. Mandall et al.
(36) reported a 3-year follow-up with increased ANB
in 86% of the initial sample, downward and back-
ward rotation of the maxilla, upward and forward
rotation of the occlusal plane and correction of the
overjet, without vertical changes (Table S5).
Discussion
The aim of this systematic review was to summarise
the effects of the orthopaedic treatment with different
appliances on growing skeletal Class III patients com-
pared with an untreated control group, assessing
skeletal, dental or soft tissues variables, and to esti-
mate the effect of study design. Class III orthopaedic
therapy includes several appliances, not always
assessed by RCTs (13, 32, 46). Other systematic
reviews comprised randomised and non-randomised
studies without evaluating if the study design could
affect the results (18–22). Indeed, an interesting find-
ing of this review was that some results may be over-
estimated due to the study design. All the
retrospective studies that chose the treatment group
with a successful criterion, or without a concurrent
control group, were excluded due to the chance of a
misinterpretation and invalidation of the study results
(47, 48). These data should be carefully assessed in
orthodontics because most of our knowledge is based
on CCT and/or retrospective studies that could not
provide an adequate evidence-based support (49).
Characteristics of the studies
Still many controversies are present in the early treat-
ment of Class III malocclusion. The age for starting
treatment varied from 5 to 13 years old, with a large
range in treatment time. In addition, the forces
applied and time-wear of the appliances differed
among studies. Only in 13 studies, the inclusion crite-
ria for the diagnosis of the skeletal Class III malocclu-
sion were based on cephalometric data or soft tissue
evaluation, while others used dental parameters.
Therefore, one crucial limit is the scarce emphasis
given to skeletal and profile evaluation, both for the
diagnosis and the treatment outcome.
Quality assessment
The Downs and Black checklist (25) was chosen to
evaluate external validity and report domains, which
are not present in other tools. Only two RCTs (14,
37) were considered of high quality with a low level
of bias. On the other hand, two CCTs (13, 44) were
of medium-high quality, higher than other RCTs,
meaning that RCTs may not always have the best
quality. The quality of the studies analysed was gener-
ally medium mainly for the lack of adequate statistics
and follow-up data.
Skeletal effects
All selected studies reported sagittal skeletal changes,
suggesting that orthopaedic therapy is effective to cor-
rect Class III malocclusions with a low or very low
level of evidence. Consistent with previous reviews
(16, 17, 19–21), ANB showed a significant change.
Not all the appliances had effects on SNA and maxil-
lary length. Only the FM in the meta-analysis, in
accordance with other studies (16, 17, 20, 21, 50, 51),
had a strong effect in the short term on both SNA
and maxillary length, with a very low level of evi-
dence, Also the CC increased SNA, but this finding
was not consistent with another meta-analysis (19).
Similarly, SNB in the meta-analysis, for FM and CC,
© 2017 John Wiley & Sons Ltd
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and Mandibular length only for FM, showed a signifi-
cant control of the mandible. Analogous results were
found for FM (16, 17, 20, 21) and for CC (19). How-
ever, it must be stressed that the sagittal control of
the mandible assessed by angular measurements
(SNB, ANB) suffers from the influence of a clockwise
rotation of the mandible, enhancing the apparent
amount of sagittal effect (52). Indeed, except for FR-
III (32), supported by one study of low quality, and
for RMR (37), supported by one RCT of high quality,
all the other appliances determined a clockwise rota-
tion of the mandible. This effect was also confirmed
in other reviews (16, 17, 19–21). Furthermore, it
should be take into account that most of the studies
started treatment in older patients and, as showed in
the moderator analysis, older patients have higher
increases in the divergence.
Hence, even if the early orthopaedic treatment of
Class III malocclusion could be effective in the short
term, it should not be recommended in hyperdivergent
Fig. 4. Meta-analyses of upper lip position (a), lower lip position (b) and profile (c) changes when comparing the orthopaedic treat-
ment with chin cup (CC) and with the facemask (FM) with no treatment. Forest plot for the standard mean including the source stud-
ies, effect sizes with 95% confidence intervals, statistical significance, number of total (N), treated (N1) untreated (N2) participants
and assessments of heterogeneity (I2).
© 2017 John Wiley & Sons Ltd
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and older patients in case the increase of the
mandibular divergence is unwanted.
Dental effects
There was a moderate level of evidence that FM cor-
rects the overjet while there was no evidence, accord-
ing to the GRADE, that FM or CC affect the overbite.
Nonetheless, in six of seven studies there was a
decrease in the overbite often associated with an
increase in mandibular divergence. This confirms the
importance of being warned about the vertical mor-
phology when treating skeletal Class III malocclusion.
Controversial data were reported for incisor inclina-
tions. The meta-analysis for the FM showed a signifi-
cant proclination of upper incisors, which was
confirmed in another study (20), while, according to
one RCT (28) CC proclined the upper incisors and
retroclined the lower incisors. Nevertheless, the
GRADE revealed a level of evidence from very low to
low.
Hence, the orthopaedic treatment corrects the over-
jet, but due to the controversial data, there is still a
lack of evidence on the molar relationship and other
dental effects.
Soft tissue effects
To our knowledge, this is the first meta-analysis of
the effects on soft tissues. Few studies reported
improvement on soft tissue (13, 31, 35, 37–39, 42–44,
46). However, the GRADE showed a very low level of
evidence for FM. It is well known that, from the
patient’s point of view, the success of the therapy is
strongly related to aesthetic improvement (53). Also a
patient’s quality of life is influenced by aesthetics (54,
55). There is the need for future studies to focus on
the objective and subjective evaluations of soft tissue
changes by taking advantage of new 3D technology
(56, 57).
Hence, although the level of evidence is very low,
the orthopaedic treatment seems to improve the facial
profile mainly in younger patients.
Follow-up
There is still insufficient follow-up evidence. Two (30)
and 3-year (36) follow-up data showed a relapse in
about 15% of patients. One 6-year follow-up study
suggested that class III protraction facemask treatment
reduces the need for orthognathic surgery in adult-
hood, indeed the group without treatment showed an
odd of needing surgery 35 times higher than the group
treated with FM. Moreover, 68% of patient treated
with FM maintained a positive overjet. Nevertheless,
no improvement in quality of life in treated patients
respect to untreated subjects was reported (9).
Hence, due to the scarce available information, it is
not possible to establish if the early functional treat-
ment prevents the relapse and the need for surgery in
adulthood, and if the early treatment has an impact
in the quality of life of skeletal Class III subjects.
One limit of this systematic review was the use of
SMD for the meta-analysis. Even though the SMD
decreases the possible discrepancies in terms of mag-
nification, variables assessed and study method error,
interpretation by clinicians is difficult. Moreover, the
inclusion of non-randomised studies could be consid-
ered a limit (58, 59), but it was supported to provide
a wider overview on this topic.
Conclusions
1 The quality of the primary studies was medium-
low. Patient selection, blinding assessment and sta-
tistical analysis were often inadequate.
2 The study design might lead to an overestimation
of the results; hence, there is a need for well
designed RCTs.
3 An improvement of the sagittal skeletal relationship
was reported with all the orthopaedic appliances,
but only a few appliances were analysed by more
than one study.
4 The FM seems to correct Class III discrepancies, but
it might determine a clockwise rotation of the
lower jaw and a decreased overbite.
5 There was controversial evidence on the dental
effects of the orthopaedic appliances; however,
there was a moderate level of evidence that the FM
corrects overjet.
6 Soft tissue improvements were reported in all the
studies assessing this outcome.
7 There was insufficient evidence to assess the long-
term stability of Class III orthopaedic treatment.
8 The level of evidence supporting the efficacy of FM
or CC varied from very low to moderate.
Further studies are needed to achieve enough infor-
mation in early treatment of Class III malocclusion;
© 2017 John Wiley & Sons Ltd
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the scarce presence of follow-up data in high quality
studies does not allow for an evaluation on stability
and utility of orthopaedic treatment in the long term.
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